News Sentiment

PDEX sentiment intelligence

Pro-Dex Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 25 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 62.89 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 25

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+2.5% over one week, +1.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Pro Dex director Domingo sells $47,145 of company stock By Investing.com

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 2.5% Price confirming higher
Trend fit Trend active 1.1% over four weeks
Fair value 84.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 7
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 25
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 3
Seeking Alpha 3
MarketBeat 3
Investing.com UK 2
Finviz 2
Bölüm Sonu Canavarı 1
Stock Traders Daily 1
MEXC 1

Event Lens

What the news is about

Classified themes
Market update 12
Earnings 9
Macro sensitivity 1
Deals and strategy 1
Analyst action 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-25 of 25
Investing.com UK Direct company coverage

Pro Dex director Domingo sells $47,145 of company stock By Investing.com

Angelita Rebamontan Domingo, a director at PRO DEX INC (NASDAQ: PDEX), recently sold 998 shares of the company's common stock for $47,145. The transaction occurred on March 16, 2026, at $47.24 per share. Following the sale, Domingo directly holds 18,779 shares, and the stock has

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 21:44
Source
Investing.com UK
Stock Titan Direct company coverage

Pro-Dex director (NASDAQ: PDEX) sells 998 shares in open market trade

A director at Pro-Dex Inc. (NASDAQ: PDEX), Domingo Angelita Rebamontan, sold 998 shares of common stock in an open-market transaction on March 16, 2026, at a price of $47.24 per share. Following this sale, the director directly holds 18,779 shares of Pro-Dex common stock. The tra

Tone
Negative 36/100
Event
Market update
Published
14 Jul 2026 21:44
Source
Stock Titan
Investing.com UK Direct company coverage

Form 4 Pro-Dex Inc For: 14 July By Investing.com

This article from Investing.com announces the filing of Form 4 for Pro-Dex Inc. on July 14. The concise piece indicates a financial disclosure but provides no further details on the content of the form. It notes the stock symbol PDEX is down 5.35%.

Tone
Negative 32/100
Event
Market update
Published
14 Jul 2026 21:44
Source
Investing.com UK
MEXC Direct company coverage

PDEX Price Today: Pro-Dex Inc New Stock Price, Quote & Chart | MEXC

This article provides current stock information for Pro-Dex Inc New (PDEX), including its latest trading price of $62.03, recent performance, and key market data. It also details the company's business activities as a designer and manufacturer of powered surgical instruments and

Tone
Positive 61/100
Event
Market update
Published
02 Jul 2026 05:09
Source
MEXC
Finviz Direct company coverage

PDEX - Pro-Dex Inc Stock Price and Quote

This article provides a comprehensive overview of Pro-Dex Inc. (PDEX) stock, including its current price, key financial metrics, performance indicators, and recent news headlines. It details the company's valuation ratios, growth rates, insider and institutional ownership, and li

Tone
Positive 61/100
Event
Macro sensitivity
Published
02 Jun 2026 16:40
Source
Finviz
Stock Titan Direct company coverage

Pro-Dex (NASDAQ: PDEX) Q3 revenue up 15% as EPS climbs to $1.20

Pro-Dex, Inc. reported a 15% increase in Q3 2026 revenue to $19.9 million and a 16% increase for the nine months ended March 31, 2026, reaching $57.1 million. Diluted EPS rose to $1.20 for the quarter and $3.27 for the nine-month period, significantly boosted by realized gains fr

Tone
Positive 63/100
Event
Earnings
Published
03 May 2026 16:39
Source
Stock Titan
ADVFN Direct company coverage

Form 8-K - Current report

Pro-Dex, Inc. (NASDAQ: PDEX) announced the completion of its acquisition of Advanced Precision Machining LLC (APM) on February 9, 2026. This acquisition, valued at approximately $8.65 million, is expected to enhance Pro-Dex's manufacturing capabilities for medical device and aero

Tone
Positive 72/100
Event
Deals and strategy
Published
12 Apr 2026 09:38
Source
ADVFN
Intellectia AI Direct company coverage

PDEX Should I Buy

The article analyzes Pro-Dex Inc (PDEX) and concludes it is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The recommendation is based on strong financial performance, positive technical indicators, and consistent growth in revenue, n

Tone
Positive 75/100
Event
Earnings
Published
30 Mar 2026 15:40
Source
Intellectia AI
Finviz - Stock Screener Direct company coverage

AIRT,PDEX Volatility & Greeks

This article provides detailed financial data and recent news for Air T Inc. (AIRT) and Pro-Dex Inc. (PDEX). Both sections include comprehensive stock performance metrics, insider ownership, key financial figures, and a chronological list of recent press releases and financial an

Tone
Neutral 50/100
Event
Market update
Published
14 Mar 2026 08:38
Source
Finviz - Stock Screener
MarketBeat Direct company coverage

Pro-Dex (NASDAQ:PDEX) Share Price Crosses Above 200 Day Moving Average - Time to Sell?

Pro-Dex (NASDAQ:PDEX) recently saw its share price cross above its 200-day moving average, trading at $39.48. Despite this technical milestone, the stock remains below its 50-day moving average, indicating mixed short-term and long-term signals. Analysts currently rate PDEX as a

Tone
Positive 64/100
Event
Market update
Published
14 Feb 2026 09:27
Source
MarketBeat
MarketBeat Direct company coverage

Pro-Dex (NASDAQ:PDEX) Stock Crosses Above 200-Day Moving Average - What's Next?

Pro-Dex (NASDAQ:PDEX) stock recently crossed above its 200-day moving average, signaling a potential bullish trend. The medical instruments supplier reported strong Q4 results, surpassing earnings and revenue estimates, and maintains healthy profitability with low leverage. Analy

Tone
Positive 72/100
Event
Earnings
Published
07 Feb 2026 09:27
Source
MarketBeat
MarketBeat Direct company coverage

Pro-Dex (NASDAQ:PDEX) Stock Crosses Above 200 Day Moving Average - Should You Sell?

Pro-Dex (NASDAQ:PDEX) recently saw its shares cross above their 200-day moving average. The company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, alongside healthy net margins and return on equity. Analysts currently rate the stock as a "

Tone
Positive 67/100
Event
Earnings
Published
07 Feb 2026 09:27
Source
MarketBeat
Simply Wall St Direct company coverage

Pro Dex (PDEX) One Off Gain Clouds 68% Trailing Earnings Growth Narrative

Pro-Dex (PDEX) reported Q2 2026 revenue of US$18.7 million and Basic EPS of US$0.67, with trailing twelve-month revenue at US$72.1 million and Basic EPS at US$3.48. Despite 68% trailing earnings growth, these figures were significantly boosted by a US$4.7 million one-off gain, ra

Tone
Neutral 50/100
Event
Earnings
Published
06 Feb 2026 04:53
Source
Simply Wall St
Orange County Business Journal Direct company coverage

Midday Stock Roundup: Pro-Dex Rises 5.6%

Pro-Dex Inc. saw its shares rise 5.6% to $41.30, with hedge funds owning a significant portion of the medical device maker. In contrast, Evolus Inc. experienced a 4.1% drop after two analyst firms lowered their price targets due to recent downgrades. The article also provides a r

Tone
Positive 75/100
Event
Analyst action
Published
26 Jan 2026 18:27
Source
Orange County Business Journal
Seeking Alpha Direct company coverage

Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount (NASDAQ:PDEX)

Pro-Dex (PDEX) manufactures powered surgical instruments and industrial air motors, serving niche markets in orthopedics, CMF, and thoracic procedures. Despite currently having a high concentration of revenue from a single customer (78% of sales), the company is considered underv

Tone
Positive 71/100
Event
Earnings
Published
18 Jan 2026 00:57
Source
Seeking Alpha
Simply Wall Street Direct company coverage

We Think Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt With Ease

Pro-Dex, Inc. (NASDAQ:PDEX) appears to manage its debt effectively, holding US$13.2m in debt against US$10.6m in cash, resulting in a net debt of US$2.69m. The company's strong balance sheet is further supported by US$6.11m more liquid assets than total liabilities. While its con

Tone
Positive 71/100
Event
Balance sheet
Published
14 Jan 2026 08:27
Source
Simply Wall Street
Defense World Direct company coverage

D.A. Davidson & CO. Increases Holdings in Pro-Dex, Inc. $PDEX

D.A. Davidson & CO. significantly increased its stake in Pro-Dex, Inc. (NASDAQ:PDEX) by 152.3% in the third quarter, now owning 26,073 shares worth $883,000. Other institutional investors also adjusted their holdings in the medical instruments supplier. Analysts have a "Moderate

Tone
Positive 66/100
Event
Earnings
Published
12 Jan 2026 09:27
Source
Defense World